The Oncology Institute, Inc. (NASDAQ:TOIIW) Sees Large Drop in Short Interest

The Oncology Institute, Inc. (NASDAQ:TOIIW) was the recipient of a significant decline in short interest during the month of May. As of May 15th, there was short interest totaling 5,294 shares, a decline of 50.8% from the April 30th total of 10,750 shares. Based on an average daily volume of 3,547 shares, the days-to-cover ratio is presently 1.5 days.

Oncology Institute Price Performance

Oncology Institute stock remained flat at $0.05 during mid-day trading on Monday. 111 shares of the company’s stock traded hands, compared to its average volume of 15,481. Oncology Institute has a one year low of $0.03 and a one year high of $0.27. The business has a 50-day moving average of $0.05 and a two-hundred day moving average of $0.10.

Oncology Institute Company Profile

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies.